(Q46516118)

English

Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma

scientific article published on 24 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

author name string

S R Parmar

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

R Bookout

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

J F Shapiro

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

R Tombleson

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

J Perkins

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

J Kim

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

B Yue

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

M Tomblyn

8

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

M Alsina

9

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

T Nishihori

10

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

language of work or name

0 references

publication date

24 March 2014

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

Bone Marrow Transplantation

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

49

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

761-766

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

https://scigraph.springernature.com/pub.10.1038/bmt.2014.56

0 references

Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

Multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

Improved survival in multiple myeloma and the impact of novel therapies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

Lenalidomide after stem-cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

Autologous hematopoietic stem-cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

International uniform response criteria for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.56

21 January 2018

Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/24662419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24662419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model

1 reference

https://pubmed.ncbi.nlm.nih.gov/24662419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24662419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support

1 reference

https://pubmed.ncbi.nlm.nih.gov/24662419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2014.56

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/24662419

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46516118&oldid=2115676581"